Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

948 recalls · Class II, newest first

Class II · Moderate risk

rocuronium 50 mg/5 mL

Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 72196-6010-1 D-1113-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. D-1111-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. D-1110-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. D-1109-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. D-1108-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. D-1107-2023
Class II · Moderate risk

All Over-The-Counter

CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.

Ongoing Temperature excursion Inmar Supply Chain Solutions, LLC D-1104-2023
Class II · Moderate risk

Capsaicin Cream 0.025%

Product mix-up: Cartons labeled Capsaicin Cream 0.025% may contain tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste

Terminated Labeling / mix-up Avkare LLC NDC 50268-195-60 D-1147-2023
Class II · Moderate risk

Sodium Fluoride 1.1%

Cases of Sodium Fluoride 1.1% Prescription Dental Toothpaste may contain cartons labeled as Capsaicin Cream 0.025% but contain correctly labeled tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste

Terminated Labeling / mix-up Avkare LLC NDC 42291-741-51 D-1146-2023
Class II · Moderate risk

DIANEAL Low Calcium

Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.

Terminated Sterility / contamination Baxter Healthcare Corporation NDC 0941-0409-06 D-1140-2023
Class II · Moderate risk

hello wild strawberry fluoride toothpaste

Labeling: Label Mix-Up: Some hello wild strawberry fluoride toothpaste, packaged in cartons labeled as hello wild strawberry fluoride toothpaste were incorrectly filled in tubes labeled as hello fresh watermelon fluoride free toothpaste.

Terminated Labeling / mix-up Colgate Palmolive Company D-1084-2023
Class II · Moderate risk

AstrinGyn (Ferric Subsulfate)

CGMP Deviations: Products not manufactured under current good manufacturing practices.

Completed cGMP deviation Ecometics, Inc. NDC 59365-6065-0 D-1101-2023
Class II · Moderate risk

activator concentrate

CGMP Deviations: Products not manufactured under current good manufacturing practices.

Completed cGMP deviation Ecometics, Inc. D-1100-2023
Class II · Moderate risk

Unguentine Ointment

CGMP Deviations: Products not manufactured under current good manufacturing practices.

Completed cGMP deviation Ecometics, Inc. D-1099-2023
Class II · Moderate risk

Alcolado Relampago

CGMP Deviations: Products not manufactured under current good manufacturing practices.

Completed cGMP deviation Ecometics, Inc. D-1098-2023
Class II · Moderate risk

Yager's Liniment

CGMP Deviations: Products not manufactured under current good manufacturing practices.

Completed cGMP deviation Ecometics, Inc. D-1097-2023
Class II · Moderate risk

Blis-To-Sol Liquid

CGMP Deviations: Products not manufactured under current good manufacturing practices.

Completed cGMP deviation Ecometics, Inc. D-1096-2023
Class II · Moderate risk

Rasagiline Tablets 0.5mg

Failed dissolution specifications - results obtained were below spec average.

Terminated Dissolution failure Aurobindo Pharma USA Inc. NDC 0378-1270-93 D-1171-2023

Recalls by year